“I looked at a few roles over the course of the last couple years, but when I looked at NuVasive, I looked at a company that has enormous opportunity for growth,” said Christopher Barry, the new CEO of NuVasive. Photo courtesy of NuVasive


Gregory Lucier is stepping down as CEO of NuVasive. He is now chairman, which one analyst said should allow him to focus on what he does best: strategy. Photo courtesy of NuVasive


CEO: Christopher Barry (on Nov. 5)

2017 Revenue: $1.029 billion

2017 Net Income: $83 million

Year Founded: 1997

Headquarters: Sorrento Valley

Stock Symbol and Exchange: NUVA on Nasdaq

Company Description: NuVasive trains spine surgeons in advanced procedures, and makes an array of spine surgery products.

San Diego-based NuVasive recently tapped a new CEO, a move analysts say looks to bring fresh perspective to an expanding company that’s nonetheless stumbled on execution and has been an acquisition target...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129